Preliminary reports suggest conolidine may inhibit unique ion channels, reducing neuronal excitability and restricting pain indicators. This system is especially suitable in neuropathic pain, where by irregular signaling will cause persistent discomfort. Also, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to agony perception. Computational docking expe... https://williamz059qps4.bloguerosa.com/profile